These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 11736861)

  • 61. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
    O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
    J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects.
    Grove A; Allam C; McFarlane LC; McPhate G; Jackson CM; Lipworth BJ
    Br J Clin Pharmacol; 1994 Dec; 38(6):527-32. PubMed ID: 7888291
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dose-proportional pharmacokinetics of budesonide inhaled via Turbuhaler.
    Kaiser H; Aaronson D; Dockhorn R; Edsbäcker S; Korenblat P; Källén A
    Br J Clin Pharmacol; 1999 Sep; 48(3):309-16. PubMed ID: 10510140
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Relative lung delivery of fluticasone propionate via large volume spacer or nebuliser in healthy volunteers.
    Dempsey OJ; Humphreys M; Coutie WJ; Lipworth BJ
    Eur J Clin Pharmacol; 2001 Nov; 57(9):637-41. PubMed ID: 11791892
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Improvement of asthma control with beclomethasone extrafine aerosol compared to fluticasone and budesonide.
    Molimard M; Martinat Y; Rogeaux Y; Moyse D; Pello JY; Giraud V
    Respir Med; 2005 Jun; 99(6):770-8. PubMed ID: 15878495
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Assessment of adrenal suppression from two new dry powder inhaler formulations of budesonide delivered by Clickhaler compared with the Pulmicort Turbuhaler.
    Kirkpatrick C; Buck H; Ellis S
    J Aerosol Med; 2003; 16(1):31-6. PubMed ID: 12737682
    [TBL] [Abstract][Full Text] [Related]  

  • 67. From hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs.
    Kunka R; Andrews S; Pimazzoni M; Callejas S; Ziviani L; Squassante L; Daley-Yates PT
    Respir Med; 2000 Jun; 94 Suppl B():S10-6. PubMed ID: 10919680
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacokinetic and pharmacodynamic comparison of hydrofluoroalkane and chlorofluorocarbon formulations of budesonide.
    Clearie KL; Williamson PA; Meldrum K; Gillen M; Carlsson LG; Carlholm M; Ekelund J; Lipworth BJ
    Br J Clin Pharmacol; 2011 Apr; 71(4):504-13. PubMed ID: 21395643
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma.
    Corren J; Korenblat PE; Miller CJ; O'Brien CD; Mezzanotte WS
    Clin Ther; 2007 May; 29(5):823-843. PubMed ID: 17697902
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Assessment of the systemic effects of budesonide inhaled from Easyhaler and from Turbuhaler in healthy male volunteers.
    Hämäläinen KM; Granander M; Toivanen P; Malinen A
    Respir Med; 2001 Nov; 95(11):863-9. PubMed ID: 11716199
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacokinetics of budesonide and formoterol administered via 1 pressurized metered-dose inhaler in patients with asthma and COPD.
    Tronde A; Gillen M; Borgström L; Lötvall J; Ankerst J
    J Clin Pharmacol; 2008 Nov; 48(11):1300-8. PubMed ID: 18974284
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lung function.
    Lee DK; Bates CE; Currie GP; Cowan LM; McFarlane LC; Lipworth BJ
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):253-8. PubMed ID: 15478385
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Deposition and pharmacokinetics of budesonide from the Miat Monodose inhaler, a simple dry powder device.
    Ball DJ; Hirst PH; Newman SP; Sonet B; Streel B; Vanderbist F
    Int J Pharm; 2002 Oct; 245(1-2):123-32. PubMed ID: 12270249
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lung deposition of budesonide from a pressurized metered-dose inhaler attached to a spacer.
    Thorsson L; Edsbäcker S
    Eur Respir J; 1998 Dec; 12(6):1340-5. PubMed ID: 9877488
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
    Aalbers R; Backer V; Kava TT; Omenaas ER; Sandström T; Jorup C; Welte T
    Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Plasma concentrations of fluticasone propionate and budesonide following inhalation: effect of induced bronchoconstriction.
    Mortimer KJ; Tattersfield AE; Tang Y; Wu K; Lewis S; Hochhaus G; Harrison TW
    Br J Clin Pharmacol; 2007 Oct; 64(4):439-44. PubMed ID: 17711540
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lung deposition of inhaled drugs increases with age.
    Onhøj J; Thorsson L; Bisgaard H
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1819-22. PubMed ID: 11069819
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids.
    Shapiro GG; Mendelson LM; Pearlman DS
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):633-40. PubMed ID: 11428735
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ex-vivo product performance of Diskus and Turbuhaler inhalers using inhalation profiles from patients with severe chronic obstructive pulmonary disease.
    Burnell PK; Small T; Doig S; Johal B; Jenkins R; Gibson GJ
    Respir Med; 2001 May; 95(5):324-30. PubMed ID: 11392571
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
    Lee DK; Fardon TC; Bates CE; Haggart K; McFarlane LC; Lipworth BJ
    Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.